OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,360 | -34.0% | 52,344 | +8.4% | 0.00% | -100.0% |
| Q2 2023 | $249,135 | +193.4% | 48,282 | +199.6% | 0.00% | – |
| Q1 2023 | $84,921 | +20.9% | 16,114 | -35.5% | 0.00% | – |
| Q4 2022 | $70,225 | -5.1% | 24,991 | +35.4% | 0.00% | – |
| Q2 2022 | $74,000 | -2.6% | 18,459 | +69.2% | 0.00% | – |
| Q4 2021 | $76,000 | -72.3% | 10,912 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $274,000 | -66.6% | 16,704 | -80.3% | 0.00% | -80.0% |
| Q1 2016 | $821,000 | – | 85,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |